Literature DB >> 9222471

The safety of laparoscopy performed by direct trocar insertion and carbon dioxide insufflation under vision.

R Woolcott1.   

Abstract

The records of 6,173 laparoscopies performed by specialist gynaecologists in the course of routine gynaecological care using the technique of direct insertion of the umbilical trocar and insufflation of carbon dioxide under vision were reviewed to ascertain the incidence of serious complications. A review of the published literature on laparoscopy methodology was also undertaken to complement the data obtained from this study. The nature of the records precluded accurate assessment of both indications and minor complications. There were 4 perforating bowel injuries (0.06%) requiring laparotomy (s small intestine, 2 large intestine). There were no cases of major vascular injury or gas embolus necessitating surgical or resuscitative measures. On 3 of the 4 occasions where bowel injury occurred the patients had undergone prior abdominal surgery and had midline vertical subumbilical incisions. Review of the published literature demonstrated bowel or vessel perforation rates (requiring laparotomy or resuscitation) of 1 in 1,000 regardless of whether the method of gaining peritoneal access was open (Hasson) technique, Verres needle insufflation, or direct trocar. Direct trocar insertion may reduce the risk of gas embolism by insufflating only after intraperitoneal replacement has been confirmed, moreover it allows immediate recognition and rapid treatment of major blood vessel laceration, both of which have been identified as being crucial in reducing laparoscopy associated mortality. When compared to other available methods of gaining peritoneal access for laparoscopy, direct trocar insertion followed by insufflation of carbon dioxide under vision can be performed with the same degree of safety for the patient. It is simply wrong to deduce from the available data that one particular technique of gaining peritoneal access is superior to another. Each have their individual advantages and disadvantages and similar morbidity when performed by experienced operators with appropriate indications. In light of this observation, each alternative should be considered by the individual surgeon to assess which would best suit his or her operating technique and the particular circumstance of each patient. Indeed preference should be given to the method with which the surgeon is most comfortable or with which he or she has the most experience.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9222471     DOI: 10.1111/j.1479-828x.1997.tb02257.x

Source DB:  PubMed          Journal:  Aust N Z J Obstet Gynaecol        ISSN: 0004-8666            Impact factor:   2.100


  6 in total

1.  [Complicated course of a laparoscopic cholecystectomy].

Authors:  H Dralle; J Neu; F Köckerling; F Klee; M W Büchler
Journal:  Chirurg       Date:  2015-09       Impact factor: 0.955

2.  A technique for open trocar placement in laparoscopic surgery using the umbilical cicatrix tube.

Authors:  Pawanindra Lal; R Sharma; R Chander; V K Ramteke
Journal:  Surg Endosc       Date:  2002-09       Impact factor: 4.584

3.  Single-port thoracoscopic surgery for pneumothorax under two-lung ventilation with carbon dioxide insufflation.

Authors:  Kook Nam Han; Hyun Koo Kim; Hyun Joo Lee; Dong Kyu Lee; Heezoo Kim; Sang Ho Lim; Young Ho Choi
Journal:  J Thorac Dis       Date:  2016-06       Impact factor: 2.895

4.  Trocar and Veress needle injuries during laparoscopy.

Authors:  M Schäfer; M Lauper; L Krähenbühl
Journal:  Surg Endosc       Date:  2000-12-12       Impact factor: 4.584

Review 5.  Taking the side of transperitoneal access for surgery in upper urinary tract.

Authors:  Mohamad E Allaf; Sam B Bhayani; Louis R Kavoussi
Journal:  Curr Urol Rep       Date:  2004-04       Impact factor: 2.862

6.  Direct trocar insertion technique: an alternative for creation of pneumoperitoneum.

Authors:  K Theodoropoulou; D R Lethaby; H A Bradpiece; T L Lo; A Parihar
Journal:  JSLS       Date:  2008 Apr-Jun       Impact factor: 2.172

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.